Tongxinluo Inhibits Oxidized Low-density Lipoprotein–induced Maturation of Human Dendritic Cells via Activating Peroxisome Proliferator-Activated Receptor Gamma Pathway-Reference-Cited by-同舟云学术

Tongxinluo Inhibits Oxidized Low-density Lipoprotein–induced Maturation of Human Dendritic Cells via Activating Peroxisome Proliferator-Activated Receptor Gamma Pathway

Published:2010-08 Issue:2 Volume:56 Page:177-183
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Su Wei,Sun Aijun,Xu Danling,Zhang Hongqi,Yang Lin,Yuan Lingyan,Jia Jianguo,Zou Yunzeng,Wu Yiling,Wang Keqiang,Ge Junbo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference31 articles.

1. Dendritic cells in atherosclerotic disease.;Niessner;Clin Immunol,2010

2. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance.;Bobryshev;Eur Heart J,2005

3. Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero-resistant and athero-prone areas of the normal aorta.;Bobryshev;Arch Histol Cytol,1995

4. Dendritic cells and the control of immunity.;Banchereau;Nature,1998

5. Guicheng, Gao Ronglin, Liu Junling. Double blind control observation of TongXinLuo capsule on treatment of patients with angina pectoris caused by coronary heart disease.;Chin New Drugs J,2000

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tongxinluo capsule as a multi-functional traditional Chinese medicine in treating cardiovascular disease: A review of components, pharmacological mechanisms, and clinical applications;Heliyon;2024-07

2. Clinical effects and mechanisms of a Chinese patent medicine, Tongxinluo capsule, as an adjuvant treatment in coronary heart disease;Heliyon;2024-03

3. Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development;European Journal of Pharmacology;2024-02

4. Mast cell activation, TLR4-NF-κB/TNF-α pathway variation in rats' intestinal ischemia-reperfusion injury and Tongxinluo's therapeutic effect;pakistan journal of pharmaceutical sciences;2020-07-01

5. Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Frontiers in Pharmacology;2018-08-03